<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: ACHN News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=achn</link><description>Latest Financial News for Achillion Pharmaceuticals, Inc.</description><language>en-us</language><lastBuildDate>Mon, 21 Dec 2009 18:28:51 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>CEO and President Sells $7.4M Worth of Biogen Idec (TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ts/091221/10650225.html?.v=1</link><description>Biogen Idec CEO and President James Mullen sells $7.4 million worth.</description><guid isPermaLink="false">yahoo_finance/602537473</guid><pubDate>Mon, 21 Dec 2009 18:28:51 Etc/GMT</pubDate></item><item><title>Anadys hepatitis C drug meets key study goals (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091217/us_anadys_pharmaceuticals_study.html?.v=1</link><description>Anadys Pharmaceuticals Inc. said Thursday its experimental hepatitis C drug is meeting key goals in a midstage clinical trial.</description><guid isPermaLink="false">yahoo_finance/3543586607</guid><pubDate>Thu, 17 Dec 2009 16:15:48 Etc/GMT</pubDate></item><item><title>Stock Watch: Beacon Equity Issues Market Alert for Achillion Pharmaceuticals Inc. (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091217/180502.html?.v=1</link><description>DALLAS -- BeaconEquity.com announces an investment report featuring Achillion Pharmaceuticals Inc. . The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.</description><guid isPermaLink="false">yahoo_finance/2248747196</guid><pubDate>Thu, 17 Dec 2009 11:50:00 Etc/GMT</pubDate></item><item><title>[$$] Rise in Commodities Drives Small-Caps Higher (at The Wall Street Journal Online)</title><link>http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12ind462m/*http%3A//online.wsj.com/article/SB10001424052748703581204574600501770957952.html?ru=yahoo&amp;mod=yahoo_hs</link><description></description><guid isPermaLink="false">yahoo_finance/3344176513</guid><pubDate>Thu, 17 Dec 2009 02:57:52 Etc/GMT</pubDate></item><item><title>Movers roundup: Darden Restaurants, Technitrol (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091216/us_movers_roundup_darden_restaurants.html?.v=2</link><description>Shares of restaurant owner Darden Restaurants Inc., which operates Olive Garden, Red Lobster and Longhorn Steakhouse, climbed after an analyst upgraded the stock.</description><guid isPermaLink="false">yahoo_finance/676943680</guid><pubDate>Wed, 16 Dec 2009 22:46:53 Etc/GMT</pubDate></item><item><title>First Bancorp, Achillion Pharmaceuticals: Biggest Price Gainers (FBP, ACHN) (at The Wall Street Journal Online)</title><link>http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12ico94j2/*http%3A//online.wsj.com/article/SB10001424052748704541004574600480537232924.html?ru=yahoo&amp;mod=yahoo_hs</link><description></description><guid isPermaLink="false">yahoo_finance/555929642</guid><pubDate>Wed, 16 Dec 2009 22:15:19 Etc/GMT</pubDate></item><item><title>AMD, Beazer, Playboy, Technitrol are big movers (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091216/us_wall_street_stocks.html?.v=4</link><description>The following stocks were among those that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:</description><guid isPermaLink="false">yahoo_finance/1328049364</guid><pubDate>Wed, 16 Dec 2009 21:55:20 Etc/GMT</pubDate></item><item><title>Achillion shares rise on hepatitis C drug data (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091216/us_achillion_pharmaceuticals_mover.html?.v=1</link><description>Shares of Achillion Pharmaceuticals Inc. surged Wednesday after the company said its hepatitis C drug candidate showed positive &quot;proof-of-concept&quot; results, while meeting safety and tolerability goals in an early-stage study.</description><guid isPermaLink="false">yahoo_finance/3423123691</guid><pubDate>Wed, 16 Dec 2009 19:33:53 Etc/GMT</pubDate></item><item><title>Emerging Stock Report Initiates Independent Research Coverage on Achillion Pharmaceuticals, Inc. (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091216/180446.html?.v=1</link><description>CALGARY, Alberta -- Emerging Stock Report, a leading provider of sector specific independent investment research, today initiated coverage on Achillion Pharmaceuticals, Inc. . Emerging Stock Report is currently offering a complimentary trial subscription to the investment community.</description><guid isPermaLink="false">yahoo_finance/3968696974</guid><pubDate>Wed, 16 Dec 2009 16:47:48 Etc/GMT</pubDate></item><item><title>UPDATE - Achillion shares surge on hepatitis C drug data (at Reuters)</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh02164_2009-12-16_16-37-29_sge5bf0ho_newsml&amp;rpc=44&amp;type=marketsNews</link><description></description><guid isPermaLink="false">yahoo_finance/3501159521</guid><pubDate>Wed, 16 Dec 2009 16:37:29 Etc/GMT</pubDate></item><item><title>Biotech Stocks: Drug stocks rise; Achillion, Sanofi in play (at MarketWatch)</title><link>http://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12mlgfs96/*http%3A//www.marketwatch.com/news/story/drug-stocks-rise-achillion-sanofi/story.aspx?guid=%7B08D39E49%2D73EB%2D4AD9%2D9AFC%2D0D78ED492B41%7D&amp;siteid=yhoof</link><description></description><guid isPermaLink="false">yahoo_finance/3869255917</guid><pubDate>Wed, 16 Dec 2009 15:36:00 Etc/GMT</pubDate></item><item><title>Achillion, Emcore: Early Volume Plays (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12tfedgli/*http%3A//www.thestreet.com/_yahoo/story/10646927/1/achillion-emcore-early-volume-plays.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/1083834771</guid><pubDate>Wed, 16 Dec 2009 12:15:44 Etc/GMT</pubDate></item><item><title>Achillion Announces Positive Preliminary Phase 1b Proof of Concept Data With ACH-1625 to Treat Hepatitis C (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091215/180386.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/4033371968</guid><pubDate>Tue, 15 Dec 2009 22:39:24 Etc/GMT</pubDate></item><item><title>ACHILLION PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091215/achn8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2644888408</guid><pubDate>Tue, 15 Dec 2009 20:36:31 Etc/GMT</pubDate></item><item><title>Achillion Regains Compliance With Nasdaq Listing Rules (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091215/180346.html?.v=1</link><description>NEW HAVEN, Conn. -- Achillion Pharmaceuticals, Inc. , a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today reported that it received notification from the NASDAQ Listings Qualification Department that it has regained compliance with NASDAQ listing rules.</description><guid isPermaLink="false">yahoo_finance/505502940</guid><pubDate>Tue, 15 Dec 2009 16:13:54 Etc/GMT</pubDate></item><item><title>ACHILLION PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091117/achn8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/594695799</guid><pubDate>Tue, 17 Nov 2009 21:59:54 Etc/GMT</pubDate></item><item><title>Achillion Receives Notice From NASDAQ (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091117/178628.html?.v=1</link><description>NEW HAVEN, Conn. -- Achillion Pharmaceuticals, Inc. , a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today reported that it received notification from the NASDAQ Listings Qualification Department that the Company&apos;s stockholders&apos; equity of $7,214,000, as reported in the Company&apos;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2009 that it filed with the Securities and Exchange Commission, does not comply with the minimum stockholders&apos; equity requirement of $10,000,000 for continued listing on The NASDAQ Global Market pursuant to NASDAQ Listing Rule 5450.</description><guid isPermaLink="false">yahoo_finance/563861593</guid><pubDate>Tue, 17 Nov 2009 21:00:00 Etc/GMT</pubDate></item><item><title>New Star Analyst Rankings for Achillion Pharmaceuticals, Inc. (StarMine)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/a/r/a/achn.html</link><description></description><guid isPermaLink="false">yahoo_finance/3633147926</guid><pubDate>Tue, 10 Nov 2009 14:24:50 Etc/GMT</pubDate></item><item><title>Morningstar Strategist Says Healthcare Bill Will Be Law By End Of Year: Is Your Portfolio Ready? (Wall Street Transcript)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/twst/091109/pharma33.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1383835371</guid><pubDate>Mon, 9 Nov 2009 18:45:00 Etc/GMT</pubDate></item><item><title>ACHILLION PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091106/achn8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/905890917</guid><pubDate>Fri, 6 Nov 2009 19:30:18 Etc/GMT</pubDate></item></channel></rss><!-- c22.finance.sp2.yahoo.com compressed/chunked Tue Dec 22 09:30:44 PST 2009 -->
